Pharmaceutical companies have strategically increased their presence in chronic therapies, focused on new product launches, and ventured into new therapies to capitalise on market opportunities.
Third-quarter revenue from continuing operations of $3.71 billion increased 3% on a reported basis and 2% on a constant currency basis, ahead of the company’s previously issued.
Mumbai (Maharashtra) [India], Aug 10 (ANI): India Ratings and Research (Ind-Ra) said on Tuesday that 13.7 per cent y-o-y revenue growth in India's pharmaceutical market during 2021 was led by continued demand normalisation post the high growth months of April and May.